JAA-F11: Extending the life of mice with breast cancer

Expert Opinion on Biological Therapy

Volumn 7, Issue 7, 2007, Pages 923-928

  Rittenhouse Olson, Kate ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Breast cancer; Carbohydrate antigens; Carcinomas; Imaging; Immunotherapy; JAA F11; Metastasis; Positron emission tomography; Prostate cancer; Radiolocalization; TF Ag; Thomsen friedenreich antigen; Tumor antigens

Indexed keywords

ANTIGEN; CARBOHYDRATE ANTIGEN; GLYCAN; IODINE 124; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JAA F11; THOMSEN FRIEDENREICH ANTIGEN; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER SURVIVAL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS;

ANIMALIA; MUS;

EID: 34547640708     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.7.7.923     Document Type: Review

References (34)

1. RITTENHOUSE-DIAKUN K, XIA Z, PICKHARDT D, MOREY S, BAEK M-G, ROY R: Development and characterization of monoclonal antibody to T-antigen: (Galβ1-3GalNAc-α-O). Hybridoma (1998) 17(2):165-173. •• The first paper on JAA-F11, it includes immunogen composition, and beginning specificity data on the monoclonal Ab.
2. HEIMBURG J, YAN J, MOREY S et al.: Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia (2006) 8(11):939-948. •• A key paper on the biologic effects of JAA-F11 in the animal model and in in vitro models of metastasis with human cancer cells.
3. FRIEDENREICH V: The Thomsen Hemagglutination Phenomenon: Production of a Specific Receptor Quality in Red Corpuscles by Bacterial Activity. Levin and Munksgaard, Copenhagen, Denmark (1930).
4. RAHMAN AF, LONGENECKER BM: A monoclonal antibody specific for the Thomsen-Friedenreich cryptic antigen. J. Immunol. (1982) 129:2021-2025.
5. SPRINGER GF, DESAI PR: Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J. Natl. Cancer Inst. (1975) 54:335-339.
6. HAKOMORI S: Tumor-associated carbohydrate antigens. Ann. Rev. Immunol. (1984) 2:103-126.
7. SPRINGER GF: T and Tn, general carcinoma autoantigens. Science (1984) 224(4654):1198-1206.
8. IRAZOQUI FJ, NORES GA: Thomsen-Friedenreich disaccharide immunogenicity. Curr. Cancer Drug Targets (2003) 3(6):433-443.
9. SCHNEIDER F, KEMMNER W, HAENSCH W et al.: Overexpression of sialyltransferase CMP-sialic acid: Galβ1,3GalNAc-R α6- sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res. (2001) 61:4605-4611.
10. TAKANAMI I: Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol. Reports (1999) 6:341-344.
11. DIPPOLD W, STEINBORN A, MEYER ZUM BUSCHENFELDE KH: The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule. Environ. Health Perspect. (1990) 88:255-257.
12. SPRINGER GF, DESAI PR: Cross-reacting carcinoma-associated antigens with blood group and precursor specificities. Transplant. Proc. (1977) 9(1):1105-1111.
13. TAKANAMI I: Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol. Reports (1999) 6:341-344. • Relation of TF-Ag expression and prognosis.
14. BLIXT O, HEAD S, MONDALA T et al.: Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA (2004) 101(49):17033-17038. •• A pivotal paper concerning this new resource that will help improve understanding of the different specificities of antibodies.
15. DE BENTZMANN S, DUPUTIT PR, BAJOLET-LAUDEINAT O et al.: Asialo GM1 is a receptor for Pseudomonas aeruginosa adherance to regenerating respiratory epithelial cells. Infect. Immun. (1996) 64:1582-1588.
16. KOVACIC N, MUTHING J, MARUSIC A: Immunohistochemical and flow cytometric analysis of glycosphingolipid expression in mouse lymphoid tissues. J. Histochem. Cytochem. (2000) 48:1677-1689.
17. ABDI EA, KAMITOMO V J, MCPHERSON T A et al.: Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function. Eur. J. Nucl. Med. (1986) 11(9):350-354.
18. MILLER GM, ANDRES ML, GRIDLEY DS: NK cell depletion results in accelerated tumor growth and attenuates the anti-tumor effect of total body irradiation. Int. J. Oncol. (2003) 1585-1592. • Important in that it shows that binding to the TF-Ag-related structure asialo-GM-1 can cause NK-cell depletion, which has a negative impact on survival.
19. YU L, ANDREWS N, ZHAO Q et al.: Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J. Biol. Chem. (2007) 282(1):773-781. •• A key paper describing experiments which showed galectin 3-mediated tumor cell adhesion to endothelial cells mediated by TF-Ag-bearing mucin-1 expression, but not by a cellular variant that contained predominantly sialyl-TF.
20. GLINSKY W, GLINSKY GV, RITTENHOUSE-OLSON K et al.: The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res. (2001) 61:4851-4857.
21. GLINSKY VV, HUFLEJT ME, GLINSKY GV, DEUTSCHER SL, QUINN TP: Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside- mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res. (2000) 60:2584-2588.
22. GLINSKII OV, HUXLEY VH, TURK JR et al.: Continuous real time ex vivo epifluorescent video microscopy for studying cancer cell interactions with dura mater microvasculature. Clin. Exp. Metastasis (2003) 20:451-458.
23. GLINSKII OV, HUXLEY VH, GLINSKY GV, PIENTA KJ, RAZ A, GLINSKY VV: Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia (2005) 5:522-527.
24. GLINSKY VV: Intravascular cell-to-cell adhesive interactions and bone metastasis. Cancer Metastasis Rev. (2006) 25:531-540. •• A well-done review on cellular interactions involved in metastasis.
25. 99mtechnetium mAb-170H.82 (Tru-Scint AD). Breast Cancer Res. Treat. (1997) 45(1):29-3. • An immunolocalization paper with an anti-TF-Ag Ab that showed promising results with an Ab, which bound both TF-Agα and -β.
26. KURTENKOV O, MILJUKHINA L, SMORODIN J et al.: Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors. Acta Oncol. (1999) 38(7):939-943.
27. DESAI PR, UJJAINWALA LH, CARLSTEDT SC, SPRINGER GF: Anti-Thomsen- Friedenreich (T) antibody-based ELISA and its application of human breast carcinoma detection. J. Immunol. Methods (1995) 188:175-185.
28. JANSSON B, BORREBACK CAK: The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies. Cancer Immunol. Immunother. (1992) 34:294-298.
29. MONTEIRO MA, CHAN KH, RASKO DA et al.: Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. (1998) 273(19):11533-11543.
30. KURTENKOV O, KLAAMAS K, RITTENHOUSE-OLSON K et al.: Expression of tumor-associated Thomsen-Friedenreich (T) antigen in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol. Invest. (2002) 31:191-204.
31. THORS C, JANSSON B, HELIN H, LINDER E: Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni: localization and immunogenicity in experimental mouse infection. Parasitology (2006)132:72-81.
32. KURTENKOV OA, KLAAMAS K, MILJUKHINA L: The lower level of natural anti-Thomsen-Friedenreich antigen (TFA) agglutinins in sera of patients with gastric cancer related to ABO(H) blood-group phenotype. Int. J. Cancer (1995) 60:781-785.
33. KURTENKOV O, KLAAMAS K, SERGEYEV B, CHUZMAROV V, MILJUKHINA L, SHLJAPNIKOVA L: Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen-Friedenreich antigen-specific antibodies. Immunol. Invest. (2003) 32(1-2):83- 93. • Anti-TF-Ag and better survival.
34. SPRINGER GF: Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis and immunotherapy. J. Mol. Med. (1997) 75:594-602. •• A nice review of the pivotal work done by Springer on TF-Ag. Includes information about his HLA-free, TF-Ag containing O red blood cell membranes as a vaccine for breast cancer patients.